Abstract
Plasminogen activator inhibitor (PAI-1), a potent inhibitor of fibrinolysis, is associated with excessive fibrin accumulation, thrombus formation, and atherosclerosis. Endothelial dysfunction (ED) occurs early in the pathophysiology of atherosclerotic coronary artery disease (CAD). We hypothesized
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
